Gil Bellis

1.3k total citations
20 papers, 623 citations indexed

About

Gil Bellis is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Infectious Diseases. According to data from OpenAlex, Gil Bellis has authored 20 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 6 papers in Epidemiology and 4 papers in Infectious Diseases. Recurrent topics in Gil Bellis's work include Cystic Fibrosis Research Advances (10 papers), Neonatal Respiratory Health Research (5 papers) and Tuberculosis Research and Epidemiology (4 papers). Gil Bellis is often cited by papers focused on Cystic Fibrosis Research Advances (10 papers), Neonatal Respiratory Health Research (5 papers) and Tuberculosis Research and Epidemiology (4 papers). Gil Bellis collaborates with scholars based in France, Switzerland and Mali. Gil Bellis's co-authors include Evelyne Le Roux, S. Ravilly, Didier Guillemot, Lydie Lemonnier, Anne‐Laure Roux, Émilie Catherinot, Brigitte Fauroux, Marie‐Anne Vibet, Jean‐Louis Gaillard and Cristina Gutierrez and has published in prestigious journals such as Journal of Clinical Microbiology, European Respiratory Journal and BJOG An International Journal of Obstetrics & Gynaecology.

In The Last Decade

Gil Bellis

19 papers receiving 612 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gil Bellis France 10 398 263 263 219 66 20 623
Lydie Lemonnier France 15 446 1.1× 668 2.5× 267 1.0× 219 1.0× 129 2.0× 34 1.1k
Leah Lande United States 13 267 0.7× 54 0.2× 181 0.7× 110 0.5× 36 0.5× 23 412
W.G. Flight United Kingdom 12 175 0.4× 290 1.1× 48 0.2× 25 0.1× 32 0.5× 35 428
Jeanette Y. Lee United States 8 348 0.9× 60 0.2× 362 1.4× 107 0.5× 41 0.6× 12 550
Charles U. Mauney United States 7 251 0.6× 12 0.0× 109 0.4× 60 0.3× 112 1.7× 12 337
Rosângela Siqueira de Oliveira Brazil 12 271 0.7× 18 0.1× 271 1.0× 34 0.2× 70 1.1× 39 354
Dayel Alshahrani Saudi Arabia 11 125 0.3× 22 0.1× 105 0.4× 62 0.3× 45 0.7× 35 375
Dana M. Harris United States 10 122 0.3× 30 0.1× 84 0.3× 33 0.2× 63 1.0× 41 280
S. K. Kabra India 13 143 0.4× 152 0.6× 112 0.4× 9 0.0× 34 0.5× 37 484
Chandramani Panjabi India 13 74 0.2× 210 0.8× 220 0.8× 52 0.2× 50 0.8× 26 506

Countries citing papers authored by Gil Bellis

Since Specialization
Citations

This map shows the geographic impact of Gil Bellis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gil Bellis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gil Bellis more than expected).

Fields of papers citing papers by Gil Bellis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gil Bellis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gil Bellis. The network helps show where Gil Bellis may publish in the future.

Co-authorship network of co-authors of Gil Bellis

This figure shows the co-authorship network connecting the top 25 collaborators of Gil Bellis. A scholar is included among the top collaborators of Gil Bellis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gil Bellis. Gil Bellis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lambert, Jérôme, et al.. (2017). A 3-year prognostic score for adults with cystic fibrosis. Journal of Cystic Fibrosis. 16(6). 702–708. 42 indexed citations
2.
Roux, Anne‐Laure, Émilie Catherinot, Nathalie Soismier, et al.. (2014). Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients. Journal of Cystic Fibrosis. 14(1). 63–69. 69 indexed citations
3.
Bournez, Marie, Gil Bellis, Catherine Pienkowski, M. Tauber, & Frédéric Huet. (2013). La croissance des filles suivies pour mucoviscidose de 8 à 20 ans : les données du registre français. Archives de Pédiatrie. 20(5). H81–H83. 1 indexed citations
4.
Lemonnier, Loïc, et al.. (2013). WS18.1 Evolution of pregnancies in the French CF Registry: 1992–2011. Journal of Cystic Fibrosis. 12. S36–S36. 1 indexed citations
5.
Bournez, Marie, Gil Bellis, & Frédéric Huet. (2012). Growth during puberty in cystic fibrosis: a retrospective evaluation of a French cohort. Archives of Disease in Childhood. 97(8). 714–720. 25 indexed citations
6.
Catherinot, Émilie, Anne‐Laure Roux, Marie‐Anne Vibet, et al.. (2012). Mycobacterium avium and Mycobacterium abscessus complex target distinct cystic fibrosis patient subpopulations. Journal of Cystic Fibrosis. 12(1). 74–80. 76 indexed citations
7.
Catherinot, Émilie, Anne‐Laure Roux, Marie‐Anne Vibet, et al.. (2012). Inhaled therapies, azithromycin andMycobacterium abscessusin cystic fibrosis patients. European Respiratory Journal. 41(5). 1101–1106. 29 indexed citations
8.
Burgel, Pierre‐Régis, Isabelle Fajac, D. Hubert, et al.. (2009). Non‐classic cystic fibrosis associated with D1152H CFTR mutation. Clinical Genetics. 77(4). 355–364. 25 indexed citations
9.
Roux, Anne‐Laure, Émilie Catherinot, Fabienne Neulat-Ripoll, et al.. (2009). Multicenter Study of Prevalence of Nontuberculous Mycobacteria in Patients with Cystic Fibrosis in France. Journal of Clinical Microbiology. 47(12). 4124–4128. 235 indexed citations
10.
Fauroux, Brigitte, Evelyne Le Roux, S. Ravilly, Gil Bellis, & Annick Clément. (2007). Long-Term Noninvasive Ventilation in Patients with Cystic Fibrosis. Respiration. 76(2). 168–174. 30 indexed citations
11.
Munck, À., Gil Bellis, S. Ravilly, & Frédéric Huet. (2007). 221* Do overweight and obesity improve clinical outcome in the French cystic fibrosis population?. Journal of Cystic Fibrosis. 6. S54–S54. 1 indexed citations
12.
Ravilly, S., et al.. (2007). Épidémiologie et physiopathologie de la mucoviscidose. Revue Francophone des Laboratoires. 2007(397). 25–36. 2 indexed citations
13.
Duguépéroux, I., D. Hubert, S. Dominique, et al.. (2006). Paternity in men with cystic fibrosis: a retrospective survey in France. Journal of Cystic Fibrosis. 5(4). 215–221. 15 indexed citations
14.
Duguépéroux, I., et al.. (2004). Cystic fibrosis at the Reunion Island (France): spectrum of mutations and genotype-phenotype for the Y122X mutation. Journal of Cystic Fibrosis. 3(3). 185–188. 6 indexed citations
15.
Bellis, Gil, et al.. (2004). Phenotype and genotype of French cystic fibrosis patients with long survival and follow-up. European Journal of Internal Medicine. 15(4). 238–241. 5 indexed citations
16.
Braekeleer, Marc De, et al.. (2002). Cystic fibrosis and pregnancy. Report from French data (1980–1999). BJOG An International Journal of Obstetrics & Gynaecology. 109(8). 912–918. 50 indexed citations
17.
Braekeleer, Marc De, et al.. (2000). Mucoviscidose et fecondite des couples porteurs du gene au Saguenay: Lac-Saint-Jean (Quebec, Canada). Population. 55(2). 359–359. 2 indexed citations
18.
Roux, François, et al.. (1998). Epidemiology and prophylaxis of endemic goitre in the Bwa village of Sirao (Mali).. PubMed. 22(1). 43–9. 1 indexed citations
19.
Génin, Emmanuelle, Gil Bellis, & Françoise Clerget‐Darpoux. (1997). Information provided by pairs of distantly affected relatives to search for genes involved in rare autosomal dominant diseases. Annals of Human Genetics. 61(1). 25–34. 1 indexed citations
20.
Ducrocq, Rolande, Mohcine Bennani Mechita, Gil Bellis, et al.. (1994). Hemoglobinopathies in the dogon country: Presence of βs, βc, and δa'genes. American Journal of Hematology. 46(3). 245–247. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026